The Framingham Study: ITS 50-year legacy and future promise

Area of Science:

• Epidemiology
• Cardiovascular Medicine
• Public Health

Background:

• The Framingham Study initiated in 1948 to investigate the coronary disease epidemic in the USA.
• Utilized a prospective epidemiological approach to understand disease prevalence, incidence, and contributing factors.

Purpose of the Study:

• Identify major risk factors for cardiovascular diseases including coronary heart disease, stroke, peripheral artery disease, and heart failure.
• Clarify misconceptions regarding conditions like isolated systolic hypertension, left ventricular hypertrophy, dyslipidemia, atrial fibrillation, and glucose intolerance.
• Establish the continuous, graded relationship between physiological measures and cardiovascular disease risk.

Main Methods:

• Prospective cohort study design.
• Longitudinal data collection on participants' health status, lifestyle, and biomarkers.
• Development of multivariate risk profiles for risk stratification.

Main Results:

• Identified key cardiovascular disease risk factors and coined the term 'risk factors'.
• Demonstrated continuous relationships between blood pressure, lipids, glucose, and cardiovascular disease risk.
• Established the total/HDL-cholesterol ratio as an efficient lipid profile for predicting coronary disease.
• Highlighted the clustering of risk factors, often promoted by insulin resistance and weight gain.
• Showed diabetes impacts women more strongly, negating their gender-based advantage.

Conclusions:

• The Framingham Study has been pivotal in understanding cardiovascular disease etiology and risk factors.
• Findings have led to improved risk assessment tools and preventative strategies.
• Ongoing research continues to explore genetic and novel biomarkers for cardiovascular disease risk.